Rigorous clinical trials for traditional Chinese herbal medicine: Challenge and opportunity
-
-
REFERENCES
[1] Vickers A.J. and Linde K. (2014). Acupuncture for chronic pain. JAMA 311:955−956 DOI:10.1001/jama.2013.285478 [2] Cheang I., Yao W., Zhou Y., et al. (2024). The traditional Chinese medicine Qiliqiangxin in heart failure with reduced ejection fraction: A randomized, double-blind, placebo-controlled trial. Nat. Med. 30:2295−2302 DOI:10.1038/s41591-024-03169-2 [3] Guo J., Chen X., Wu M., et al. (2024). Traditional Chinese medicine FYTF-919 (Zhongfeng Xingnao oral prescription) for the treatment of acute intracerebral haemorrhage: A multicentre, randomised, placebo-controlled, double-blind, clinical trial. Lancet 404:2187−2196 DOI:10.1016/S0140-6736(24)02261-X [4] Song J., Lyu Y., Wang P., et al. (2018). Treatment of Naoxueshu promotes improvement of hematoma absorption and neurological function in acute intracerebral hemorrhage patients. Front. Physiol. 9:933 DOI:10.3389/fphys.2018.00933 [5] Ji H., Zhao X., Chen X., et al. (2024). Jinlida for diabetes prevention in impaired glucose tolerance and multiple metabolic abnormalities: The FOCUS randomized clinical trial. JAMA Intern. Med. 184:727−735 DOI:10.1001/jamainternmed.2024.1190 -
ABOUT THIS ARTICLE
Cite this article:
Wang Z., Xu D. and Chen X. (2025). Rigorous clinical trials for traditional Chinese herbal medicine: Challenge and opportunity. The Innovation Medicine 3:100117. https://doi.org/10.59717/j.xinn-med.2025.100117
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Wang Z., Xu D. and Chen X. (2025). Rigorous clinical trials for traditional Chinese herbal medicine: Challenge and opportunity. The Innovation Medicine 3:100117. https://doi.org/10.59717/j.xinn-med.2025.100117
Format
Content
DownLoad:
-
Figure 1.
Clinical trial design and pharmacological activities of FYTF-919
